3,172 papers found
Refreshing results…
Investigation of the Ballistic Performance of GFRP Laminate under 150 m/s High-Velocity Impact: Simulation and Experiment
Ionic Transport and Sieving Properties of Sub-nanoporous Polymer Membranes with Tunable Channel Size
Crystal structure of 7-chloro-N-(4-iodobenzyl)-1,2,3,4-tetrahydroacridin-9-amine, C20H18ClIN2
Multi-Scale Frequency Bands Ensemble Learning for EEG-Based Emotion Recognition
Transcatheter and Surgical Aortic Valve Replacement in Patients With Previous Cardiac Surgery: A Meta-Analysis
Selective glycerol esterification to monolaurate over ZrO2/MCM-41 catalysts prepared using impregnation and precipitation methods
An improved batch fluidized drying experimental design based on digital sensors and a minicomputer
"3G" Trial: An RNA Editing Signature to Guide Gastric Cancer Chemotherapy
A cloud-based monitoring system for performance analysis in IoT industry
Effects of different kinds of polysaccharides on the properties and inhibition of Monilinia fructicola of the thyme essential oil-chitosan based composite films
Field‐Free Manipulation of Skyrmion Creation and Annihilation by Tunable Strain Engineering
Idiopathic intracranial hypertension presenting as iron deficiency anemia: a case report
Emissions, measurement, and control of odor in livestock farms: A review
Electric control of magnetic properties in epitaxially grown FeRh/MgO/PMN-PT heterostructures
Probing the dynamical behavior in glass transition of PVPh-PEO blend
Terrain gradient variations in ecosystem services of different vegetation types in mountainous regions: Vegetation resource conservation and sustainable development
Effects of regular dance therapy intervention on blood pressure in hypertension individuals: a systematic review and meta-analysis
Effect of Simulated Muscle Activation Level on Driver Neck Response in Frontal Motor Vehicle Crashes
A phase II study of infigratinib in previously treated advanced/metastatic cholangiocarcinoma with FGFR gene fusions/alterations.
Final results from a phase II study of infigratinib (BGJ398), an FGFR-selective tyrosine kinase inhibitor, in patients with previously treated advanced cholangiocarcinoma harboring an FGFR2 gene fusion or rearrangement.
Missing publications? Read more about our data sources.